We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,231
Increased
3,688
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QQQI icon
5301
NEOS Nasdaq 100 High Income ETF
QQQI
$14B
$328K ﹤0.01%
+6,363
New +$322K
CDLX icon
5302
Cardlytics
CDLX
$21.5M
$328K ﹤0.01%
3,989
-3,883
-49% -$420K
TAC icon
5303
TransAlta
TAC
$3.93B
$327K ﹤0.01%
46,219
+11,701
+34% +$80.1K
RIGS icon
5304
ALPS Strategic Income Fund
RIGS
$60.8M
$326K ﹤0.01%
14,416
-74,896
-84% -$1.7M
CIM
5305
CALL
Chimera Investment
CIM
$1B
$326K ﹤0.01%
+25,500
New +$323K
BWG
5306
BrandywineGLOBAL Global Income Opportunities Fund
BWG
$131M
$326K ﹤0.01%
39,467
+332
+0.8% +$2.74K
SENEA icon
5307
Seneca Foods Class A
SENEA
$1.21B
$326K ﹤0.01%
5,673
-933
-14% -$54.4K
NXC
5308
DELISTED
Nuveen CA Select Tax-Free Income Portfolio
NXC
$325K ﹤0.01%
25,063
-82
-0.3% -$1.08K
LBRDA icon
5309
Liberty Broadband Class A
LBRDA
$5.16B
$324K ﹤0.01%
5,938
+424
+8% +$22K
SLSR
5310
Solaris Resources
SLSR
$1.34B
$324K ﹤0.01%
+116,083
New +$400K
JLS icon
5311
Nuveen Mortgage and Income Fund
JLS
$94.7M
$323K ﹤0.01%
17,947
+319
+2% +$5.62K
HIVE
5312
HIVE Digital Technologies
HIVE
$777M
$323K ﹤0.01%
104,893
+91,498
+683% +$257K
BCYC
5313
Bicycle Therapeutics
BCYC
$292M
$323K ﹤0.01%
15,935
+5,953
+60% +$134K
TOL icon
5314
CALL
Toll Brothers
TOL
$14.5B
$323K ﹤0.01%
2,800
-13,000
-82% -$1.57M
TOL icon
5315
PUT
Toll Brothers
TOL
$14.5B
$323K ﹤0.01%
2,800
-13,000
-82% -$1.57M
SHCR
5316
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$322K ﹤0.01%
238,413
-105,442
-31% -$86.6K
DAUG icon
5317
FT Vest US Equity Deep Buffer ETF August
DAUG
$374M
$322K ﹤0.01%
8,502
+6,654
+360% +$248K
HDB icon
5318
CALL
HDFC Bank
HDB
$121B
$322K ﹤0.01%
10,000
-40
-0.4% -$1.17K
CART icon
5319
CALL
Maplebear
CART
$11.8B
$321K ﹤0.01%
10,000
-4,221,453
-100% -$145M
CHRS icon
5320
Coherus Oncology
CHRS
$196M
$321K ﹤0.01%
185,540
+63,670
+52% +$128K
DEEF icon
5321
Xtrackers FTSE Developed ex US Multifactor ETF
DEEF
$56.9M
$321K ﹤0.01%
11,254
-323
-3% -$9.43K
BNT
5322
Brookfield Wealth Solutions
BNT
$12.2B
$320K ﹤0.01%
11,550
+8,415
+268% +$234K
EIG icon
5323
Employers Holdings
EIG
$889M
$320K ﹤0.01%
7,508
-11,578
-61% -$493K
BUFQ icon
5324
FT Vest Fund of Nasdaq-100 Buffer ETFs
BUFQ
$1.55B
$320K ﹤0.01%
10,824
+9,899
+1,070% +$284K
FLG.PRU
5325
Flagstar Bank National Association Bifurcated Option Note Unit Securities
FLG.PRU
$118M
$320K ﹤0.01%
10,006
+8,075
+418% +$261K

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.